NEWS


Inolex rolls out climate change action plan


US personal care ingredients maker Inolex is set to roll out its carbon reduction targets in a steadfast commitment to climate action. The Philadelphia company is


committing to decarbonization formally through The Science Based Targets initiative (SBTi) and through CDP (formerly Carbon Disclosure Project). Inolex has been disclosing


to CDP on climate progress since 2022, as a measure and transparency effort in carbon management. In 2024, for the first time


disclosing as a small-to-medium- sized enterprise, Inolex earned a B, the highest available score to SMEs.


This year, Inolex also received approval of its decarbonization


commitment through SBTi, a corporate climate action organization that enables companies and financial institutions worldwide to properly account for their greenhouse gas emissions. Inolex anticipates receiving


validation of its near-term target through SBTi to announce its specific targets later this year. In a related development,


Inolex has appointed Bradley Cook as its executive vice-president,


global head of manufacturing. He will lead all manufacturing


operations as the company looks to scale up its sustainable ingredient technologies through a network of production sites around the world. Previously Croda’s North


American operations vice- president and Evonik’s global vice-president of production and technology for its Care Solutions business line, Cook has an extensive career in the speciality chemicals industry focusing on engineering, supply chain, and global manufacturing strategy. He will now oversee Inolex’s flagship US manufacturing site in Charlotte, North Carolina, as well as manufacturing in France, Korea, India, and Brazil.


Sun Chemical to apply US tariff surcharge


US personal care ingredients maker Sun Chemical is to implement a tariff surcharge on impacted colour materials products, including pigments, both imported and produced in the United States. The effective date and amount


of the surcharge will vary by country and will be communicated directly to affected customers. The Parsippany, New Jersey outfit said the move is to address rising costs caused by recent global trade developments affecting raw material tariffs. “Despite the high share


of domestic production and


sourcing, the recently installed tariffs significantly impact costs for base chemicals, raw materials, equipment parts and supply chain operations,” the company said in a statement. On 2 April, the US declared


broad trade tariffs on its imports, with reciprocal tariffs being imposed on goods from over 60 countries.


Currently, additional tariffs of 10% for most countries are in place. With facilities across the


Americas, Europe and Asia, Sun Chemical - a subsidiary of Sun Chemical Group Coöperatief in the Netherlands – said it maintains the most balanced manufacturing footprint in the pigments industry and is committed to leveraging its global presence and supply chain network to mitigate cost impacts. “As the tariff situation continues


to evolve, we are committed to adjusting our approach fairly while pursuing supply chain options to mitigate the tariff impact.” it added.


Symrise cosmetic ingredients sales slide in Q1


Symrise said first quarter 2025 sales in its Cosmetic Ingredients division were lower than during the same period a year earlier. This was due to “very high


comparables in sunscreen filters,” the German speciality chemicals maker said in a statement. “The division remains


strategically well positioned with a differentiated product offering — including micro protection, cosmetic actives, botanicals, and sunscreen filters — and is


www.personalcaremagazine.com


expected to return to superior, above market growth rates going forward,” it added. Symrise’s Scent & Care


segment — comprising its activities in fragrance applications, aroma chemicals and cosmetic ingredients — recorded overall sales growth of 1.7% in the first quarter. Sales increased slightly to €518m ($590m), up on Q1 2024 revenue of €516m. Overall, Symrise had a healthy start into the 2025 fiscal year, with


organic growth of 4.2% in the first quarter. Reported group sales rose 2%


to €1.317 billion (Q1 2024: €1.292 billion) supported by the strength of its “diversified, innovation- led portfolio as well as higher volumes across both segments and sustained customer demand”. Dr. Jean-Yves Parisot, CEO


of Symrise AG, said: “We are capturing growth and enhancing margin quality through focused execution of our One Symrise


strategy, continuous investments in innovation, and stronger alignment across our businesses. “We remain confident in our


outlook for the current year and in our ability to deliver profitable above-market growth through 2028.”


June 2025 PERSONAL CARE


Evonik presses pause on


acquisitions German chemicals giant Evonik has pressed pause on new acquisitions until at least 2027, according to CEO Christian Kullmann. In a newspaper interview with


Rheinische Post, Kullmann said it will instead focus on the largest restructuring in the company’s history. “Our triple-step strategy – save,


restructure, and grow – is complex enough. We’ll look beyond 2027,” said Kullmann. Evonik last year announced


plans to cut up to 2,000 jobs worldwide by the end of 2026 in an effort to make annual cost savings of €400m ($454m). The company will decide on


the future of its service units at the Marl and Wesseling sites, which employ 3,600 staff by 2026, Kullmann said, adding that all options were on the table, including retaining the units, forming a joint venture, and selling them to investors or to chemical park operators. Evonik has made 16 acquisitions


since 2016, according to market research and data platform Tracxn. In the personal care space,


acquisitions made during that time include Novachem, Botanica, innoHealth, Infinitec Activos and Dr. Straetmans.


9


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92